The European Lung Cancer Congress (ELCC 2023) is organized by leading multidisciplinary societies in the field of thoracic oncology, to advance scientific knowledge, provide education, and enhance the expertise of lung cancer specialists globally. The program for ELCC 2023 was held both in-person in Copenhagen, Denmark, and online from March 29th to April 1st, 2023. DelveInsight is featuring summary of key abstracts focusing on long term benefits presented at the conference that have noteworthy clinical importance and is able to differentiate the data on the basis of which the drug received the approval, with the follow-up data.
Highlights:
Regeneron’s LIBTAYO ...
